fig1
![Management of type 2 diabetes after metabolic bariatric surgery](https://image.oaes.cc/3b7e45ee-9075-4a19-bc96-3ca2f7b934df/mis7080.fig.1.jpg)
Figure 1. Medical management of diabetes in metabolic-bariatric surgery patients[52]. DPP4i: Dipeptidyl peptidase-4 inhibitor; GLP-1: glucagon-like peptide-1; RA: receptor agonist; SGLT2i: sodium-glucose transporter-2 inhibitor; VLCD: very low-calorie diet.